Despite treatment advances, kidney disease burden remained unchanged over the past decade ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

If diabetes runs in your family, it's natural to worry whether your children will develop the condition too. Many parents ...

Type 1 and type 2 diabetes affect how the body turns food into energy, resulting in blood sugar that is too high. But the reason that happens is not the same, according to an endocrinologist.

Type 1.5 diabetes is often mistaken for type 2. Here is how to tell the difference and why the diagnosis matters.

A review highlights hearing loss as a hidden complication of type 2 diabetes. It notes that roughly 1 in 4 experience hearing ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who ...

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

Novo Nordisk launched Awiqli, a once-weekly insulin, in India to treat type 1 and 2 diabetes. It aims to reduce injection ...

Type 2 diabetes remission is possible with early intervention, significant weight loss and evidence-based care, but it's not ...